An augmented release of endothelin-1 and/or its reduced pulmonary clearance in HAPE-susceptible mountaineers was hypothesized to represent one of the mechanisms contributing to exaggerated pulmonary hypertension at high altitude [34]. The gene discussed is EDN1; the disease is pulmonary hypertension.